Seeing Is Believing
 Healthcare - Sector
                            Healthcare - Sector
                    
                    IMVT is currently covered by 8 analysts with an average price target of $35.3. This is a potential upside of $13.65 (63.05%) from yesterday's end of day stock price of $21.65.
Immunovant 's activity chart (see below) currently has 144 price targets and 114 ratings on display. The stock rating distribution of IMVT is 88.24% BUY and 11.76% HOLD.
Analysts average stock forecasts to be materialized ratio is 59.27% with an average time for these price targets to be met of 179.17 days.
Highest price target for IMVT is $61, Lowest price target is $16, average price target is $33.86.
Most recent stock forecast was given by DANIELLE BRILL from TRUIST on 13-Oct-2025. First documented stock forecast 06-Jan-2020.
Currently out of the existing stock ratings of IMVT, 15 are a BUY (88.24%), 2 are a HOLD (11.76%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$16
$-2.94 (-15.52%)
$36
16 days ago
(13-Oct-2025)
2/4 (50%)
$-1.49 (-8.52%)
35
Buy
$33
$14.06 (74.23%)
$37
1 months ago
(29-Sep-2025)
0/4 (0%)
$16.88 (104.71%)
Buy
$35
$16.06 (84.79%)
$51
1 months 26 days ago
(03-Sep-2025)
11/21 (52.38%)
$18.88 (117.12%)
268
Buy
$30
$11.06 (58.39%)
$33
2 months 18 days ago
(11-Aug-2025)
1/4 (25%)
$14.79 (97.24%)
126
Hold
$17
$-1.94 (-10.24%)
$41
6 months 8 days ago
(21-Apr-2025)
2/6 (33.33%)
$2.75 (19.30%)
41
What is IMVT (Immunovant ) average time for price targets to be met?
Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?
Which analyst has the most public recommendations on IMVT (Immunovant )?
Which analyst is the currently most bullish on IMVT (Immunovant )?
Which analyst is the currently most reserved on IMVT (Immunovant )?